Pharma

Pharma

Early Stage

Pharma the Movie

Pharma the Movie

Overview

Raised to Date: Raised: $468,980

Total Commitments ($USD)

Platform

Wefunder

Start Date

09/20/2023

Close Date

01/21/2024

Min. Goal
$100,000
Max. Goal
$4,564,453
Min. Investment

$100

Security Type

Equity - Preferred

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.25

Pre-Money Valuation

$8,763,182

Rolling Commitments ($USD)

Status
Funded
Reporting Date

01/30/2024

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$3,844

# of Investors

488

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2020

Industry

Media, Entertainment & Publishing

Tech Sector

MediaTech

Distribution Model

B2C

Margin

Medium

Capital Intensity

High

Location

MARIETTA, Georgia

Business Type

Life Style

Pharma, with a valuation of $8.76 million, is raising funds on Wefunder. It is a film based on the true story of Dr. Frances “Frankie” Kelsey, who fought to keep a dangerous drug from being approved for the US market. Frankie risked her career and family, waged war against big Pharma in 1960, and resisted threats from inside the FDA. Ashley Bratcher founded Pharma in March 2020. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $4.6 million. The campaign proceeds will be used for marketing, hiring key personnel, crew and production costs, and post-production costs.

Summary Profit and Loss Statement

FY 2022 FY 2021

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-25,080

$-18,425

Summary Balance Sheet

FY 2022 FY 2021

Cash

$14,869

$102,454

Accounts Receivable

$0

$0

Total Assets

$148,184

$173,204

Short-Term Debt

$60

$0

Long-Term Debt

$0

$0

Total Liabilities

$60

$0

Financials as of: 09/20/2023
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Pharma the Movie 04/28/2024 Wefunder $9,300,000 $89,075 Equity - Preferred Active RegCF
Pharma 01/20/2024 Wefunder $8,763,182 $468,980 Equity - Preferred Funded RegCF
Pharma 04/27/2023 Angel Funding - $572,112 Equity - Preferred Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Pharma on Wefunder 2023
Platform: Wefunder
Security Type: Equity - Preferred
Valuation: $8,763,182
Price per Share: $1.25

Follow company

Follow Pharma on Wefunder 2023

Buy Pharma's Deal Report

Warning: according to the close date for this deal, Pharma may no longer be accepting investments.

Pharma Deal Report

Get KingsCrowd’s comprehensive report on Pharma including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Pharma is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Pharma deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge